Skip to Content

JKI 11 (Xeljanz XR 11 mg)

Generic Name: tofacitinib

Pill with imprint JKI 11 is Pink, Elliptical / Oval and has been identified as Xeljanz XR 11 mg. It is supplied by Pfizer Inc..

Xeljanz XR is used in the treatment of rheumatoid arthritis; psoriatic arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz XR 11 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for JKI 11

Xeljanz XR

Generic Name:
tofacitinib
Imprint:
JKI 11
Strength:
11 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antirheumatics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer Inc.
National Drug Code (NDC):
00069-0501

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide